70934-0206 Ondansetron

Product NDC:

70934-0206

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 70934-0206-83

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-206-83)

Effective Date: Feb. 6, 2020

Discontinued:

Code: 70934-0206-87

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-206-87)

Effective Date: July 19, 2019

Discontinued:

Code: 70934-0206-88

Description: 8 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-206-88)

Effective Date: Feb. 15, 2019

Discontinued:

Code: 70934-0206-95

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-206-95)

Effective Date: Feb. 4, 2019

Discontinued:

Code: 70934-0206-99

Description: 12 TABLET, ORALLY DISINTEGRATING in 1 BAG (70934-206-99)

Effective Date: Feb. 12, 2019

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox